Clinical Trials Browser

Phase 1/2 × Hematologic Neoplasms × 1-dodecylpyridoxal × Clear all

NCT00750815 2014-01-20

Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)

Phase 1/2 Completed

58 enrolled 11 charts

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms